Jan 14, 2025 6:30am EST Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
Jan 06, 2025 7:55am EST NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Dec 11, 2024 8:05am EST NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
Dec 09, 2024 8:10am EST NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
